The Dividend Yield as of December 2024 (TTM) for GH Research PLC (GHRS) is 0%

According to GH Research PLC’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

GH Research PLC (GHRS) Historical Dividend Yield (quarterly & annually)

How has GHRS Dividend Yield performed in the past?

The mean historical Dividend Yield of GH Research PLC over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), GHRS's Dividend Yield was at its highest in in the March 2020 quarter at 0%. The Dividend Yield was at its lowest in in the March 2020 quarter at 0%.

GH Research PLC (GHRS) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of GH Research PLC Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

GH Research PLC (GHRS) Average Dividend Yield

How has GHRS Dividend Yield performed in the past?

The current Dividend Yield of GH Research PLC (GHRS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

GH Research PLC (GHRS) Dividend Yield vs. Peers

How is GHRS’s Dividend Yield compared to its peers?

GH Research PLC’s Dividend Yield is less than Molecular Partners AG (0%), less than MediciNova, Inc. (0%), less than Anebulo Pharmaceuticals, Inc. (0%), less than Champions Oncology, Inc. (0%), less than Cyteir Therapeutics, Inc. (0%), less than Mineralys Therapeutics, Inc. (0%), less than Eliem Therapeutics, Inc. (0%), less than Janux Therapeutics, Inc. (0%), less than Rezolute, Inc. (0%), less than PMV Pharmaceuticals, Inc. (0%), less than Pharvaris N.V. (0%), less than PepGen Inc. (0%), less than Monte Rosa Therapeutics, Inc. (0%), less than Design Therapeutics, Inc. (0%), less than Werewolf Therapeutics, Inc. (0%), less than Ikena Oncology, Inc. (0%), less than Stoke Therapeutics, Inc. (0%), less than Arcus Biosciences, Inc. (0%), less than Cullinan Oncology, Inc. (0%), less than Annexon, Inc. (0%), less than Structure Therapeutics Inc. (0%), less than Relay Therapeutics, Inc. (0%),

Build a custom stock screener for GH Research PLC (GHRS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GH Research PLC using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

GH Research PLC (GHRS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like GH Research PLC or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.